Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled With Metformin; A Narrative Review. IJPHRD 2020, 11 (7), 1063-1069. https://doi.org/10.37506/ijphrd.v11i7.10232.